Results 151 to 160 of about 461,308 (260)

DOCK8 deficiency presenting with sclerosing cholangitis, raised immunoglobulin E, and bronchiectasis: A fatal pediatric case report

JPGN Reports, EarlyView.
Abstract Dedicator of cytokinesis 8 (DOCK8) deficiency is a rare autosomal recessive primary immunodeficiency. Patients with DOCK8 deficiency typically present at early age with allergic manifestations, cutaneous and respiratory infections, raised immunoglobulin E, and they have an increased risk of developing malignancies.
Natalia Nedelkopoulou, Kelechi Ugonna, Stephen Hughes, Sanjay Rajwal, Marumbo Mtegha   +4 more
wiley   +1 more source

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Clinical Infectious Diseases, 2012
Y. Taur, J. Xavier, Lauren Lipuma, C. Ubeda, J. Goldberg, Asia Gobourne, Yeon Joo Lee, K. Dubin, N. Socci, A. Viale, M. Perales, R. Jenq, M. V. D. van den Brink, E. Pamer   +13 more
semanticscholar   +1 more source

Immune cell reconstitution after allogeneic hematopoietic stem cell transplantation in children with β-thalassemia major. [PDF]

Transl Pediatr
Zhou Y, Zhang L, Meng Y, Lei X, Jia L, Guan X, Yu J, Dou Y.   +7 more
europepmc   +1 more source

Delayed Time to First Skin Cancer Among Hematopoietic Stem Cell Transplant Recipients With Chronic Cutaneous Graft‐Versus‐Host Disease

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hematopoietic stem cell transplant (HSCT) recipients face an increased risk of cutaneous malignancies. Chronic cutaneous graft‐versus‐host disease (cGVHD), specific to allogeneic HSCT (alloHSCT), has been proposed to further elevate this risk, though its impact on skin cancer latency and distribution remains unclear.
Amy J. Petty, Vanessa Lazaro‐Camp, Melodi Javid Whitley   +2 more
wiley   +1 more source

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

Journal of the American Medical Association (JAMA), 2014
J. V. van Laar, D. Farge, J. Sont, K. Naraghi, Z. Marjanovic, J. Larghero, A. Schuerwegh, E. Marijt, M. Vonk, A. Schattenberg, M. Matucci-Cerinic, A. Voskuyl, A. A. van de Loosdrecht, T. Daikeler, I. Kötter, M. Schmalzing, T. Martin, B. Lioure, S. Weiner, A. Kreuter, C. Deligny, J. Durand, P. Emery, K. Machold, F. Sarrot-Reynauld, K. Warnatz, D. Adoue, J. Constans, H. Tony, N. Del Papa, A. Fassas, A. Himsel, D. Launay, A. Lo Monaco, P. Philippe, I. Quéré, É. Rich, R. Westhovens, B. Griffiths, R. Saccardi, F. V. D. van den Hoogen, W. Fibbe, G. Socié, A. Gratwohl, A. Tyndall   +44 more
semanticscholar   +1 more source

Impact of cryotherapy on incidence and severity of oral mucositis in hematopoietic stem cell transplantation: retrospective observational study. [PDF]

Sci Rep
Piotrowska O, Zuchmańska A, Kulig P, Michowski T, Szulc J, Skórka P, Dorsz D, Machaliński B, Milczarek S.   +8 more
europepmc   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Pharmacokinetic variability of vancomycin in patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study in Peru. [PDF]

Ther Adv Drug Saf
Bolaños-Vargas W, Copaja-Corzo C, Wong-Chang A, Santamaria-Leandro K, Aliaga-Tabraj L, Fernandez-Puycan M, Luque-Mamani AY.   +6 more
europepmc   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

Donor pretreatment with FLT-3 ligand augments anti-donor CTL, NK and LAK cell activities within liver allografts and alters the pattern of intragraft apoptotic activity [PDF]

, 1998
Chambers, FG, Fu, F, Fung, JJ, Li, W, Lu, L, Pan, F, Qian, S, Starzl, TE, Steptoe, RJ, Thomson, AW   +9 more
core